Nomura Holdings’s Acadia Pharmaceuticals ACAD Stock Holding History

Nomura Holdings’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$442K	Buy	+17,456	New	+$384K	﹤0.01%	1538
2025 Q4	–	Sell	-101,950	Closed	-$2.44M	–	1868
2025 Q3	$2.18M	Buy	+101,950	New	+$2.41M	﹤0.01%	1108
2023 Q2	–	Sell	-365,662	Closed	-$6.88M	–	1331
2023 Q1	$6.88M	Sell	365,662 -562,204	-61%	-$10.7M	0.02%	464
2022 Q4	$14.8M	Buy	927,866 +861,409	+1,296%	+$13.5M	0.06%	234
2022 Q3	$1.09M	Sell	66,457 -9,355	-12%	-$152K	﹤0.01%	932
2022 Q2	$1.09M	Buy	+75,812	New	+$1.41M	﹤0.01%	935
2014 Q3	–	Sell	-16,291	Closed	-$366K	–	2734
2014 Q2	$366K	Buy	+16,291	New	+$340K	﹤0.01%	1989
2013 Q4	–	Sell	-85,094	Closed	-$2.34M	–	1967
2013 Q3	$2.34M	Buy	+85,094	New	+$1.78M	0.01%	779

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nomura Holdings's ACAD Position: Q2 2026 in Review

Nomura Holdings opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2026: 17,456 shares worth $442K. The stake represents ﹤0.01% of the portfolio and ranks #1538 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in ACAD as recently as Q3 2025.

Nomura Holdings first reported a position in ACAD in Q3 2013 and has held it in 8 quarters since. The position peaked at $14.8M in Q4 2022. 353 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

Nomura Holdings held 17,456 shares of Acadia Pharmaceuticals worth $442K as of Q2 2026.
Acadia Pharmaceuticals was a new Nomura Holdings position in Q2 2026.
Acadia Pharmaceuticals made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1538 holding.
Nomura Holdings first reported a position in Acadia Pharmaceuticals in Q3 2013 and has held it in 8 quarters since.
Nomura Holdings's Acadia Pharmaceuticals position peaked at $14.8M in Q4 2022.
353 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.